Literature DB >> 25752222

Chikungunya infection: self-reported rheumatic morbidity and impaired quality of life persist 6 years later.

C Marimoutou1, J Ferraro2, E Javelle2, X Deparis3, F Simon2.   

Abstract

This study presents the 6-year follow-up of French gendarmes exposed to the chikungunya (CHIK) infection in 2006 on Reunion Island. The aim was to see to what extent the subjective health differences observed in 2008 (30 months after infection) between CHIK infected (CHIK+) and noninfected (CHIK-) gendarmes still persisted in 2012, and to investigate a possible return to a pre-CHIK health status for CHIK+ subjects. Gendarmes were contacted by mail in 2012 and asked to complete a self-questionnaire asking for morbidity, health care and medicines consumption since the last follow-up in 2008. Quality of life (QoL) after 6 years was evaluated using the SF-36 scale. In comparison with CHIK- subjects (n = 171), CHIK+ (n = 81) presented with higher rheumatic but also nonspecific morbidity such as headaches and fatigue associated with a large psychological impact, frequent depressive moods and social disabilities, leading to a significant impairment of the QoL and higher health care consumption. When restricted to CHIK+ subjects, comparing the data with that of 2008 showed persistent but decreasing self-reported rheumatic morbidity, and an increase over time of chronic discomfort (headache, fatigue) and depressive moods, resulting in no overall improvement in QoL. Despite possible cohort attrition bias, the comparability of CHIK+/CHIK- subjects allows the assumption of a long-term impact of CHIK infection with less chance of returning to a previous health status. Although these results may be specific to the 2006 virus strain, we recommend that public health strategies in the epidemic-prone countries include a response to the consequences of chronic post-CHIK disorders.
Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chikungunya; cohort study; health care consumption post-chikungunya rheumatic disorders; quality of life

Mesh:

Year:  2015        PMID: 25752222     DOI: 10.1016/j.cmi.2015.02.024

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  21 in total

Review 1.  Management of chikungunya arthritis.

Authors:  J Kennedy Amaral Pereira; Robert T Schoen
Journal:  Clin Rheumatol       Date:  2017-08-03       Impact factor: 2.980

2.  Brief report: the disability of chronic chikungunya arthritis.

Authors:  J Kennedy Amaral; Joshua B Bilsborrow; Robert T Schoen
Journal:  Clin Rheumatol       Date:  2019-04-08       Impact factor: 2.980

3.  Occurrence of Chronic Stage Chikungunya in the General Population of Martinique during the First 2014 Epidemic: A Prospective Epidemiological Study.

Authors:  Brieg Couzigou; Anne Criquet-Hayot; Emilie Javelle; Sandrine Tignac; Edith Mota; François Rigaud; Alizé Alain; Odile Troisgros; Sandrine Pierre-Francois; Sylvie Abel; Rishika Banydeen; André Cabié
Journal:  Am J Trop Med Hyg       Date:  2018-05-24       Impact factor: 2.345

Review 4.  Animal Models of Chikungunya Virus Infection and Disease.

Authors:  Nicole N Haese; Rebecca M Broeckel; David W Hawman; Mark T Heise; Thomas E Morrison; Daniel N Streblow
Journal:  J Infect Dis       Date:  2016-12-15       Impact factor: 5.226

5.  Post-Chikungunya Virus Infection Musculoskeletal Disorders: Syndromic Sequelae after an Outbreak.

Authors:  Hisham A Imad; Wasin Matsee; Sajikapon Kludkleeb; Punyisa Asawapaithulsert; Juthamas Phadungsombat; Emi E Nakayama; Keita Suzuki; Pornsawan Leaungwutiwong; Watcharapong Piyaphanee; Weerapong Phumratanaprapin; Tatsuo Shioda
Journal:  Trop Med Infect Dis       Date:  2021-04-15

6.  Chronic Chikungunya Virus Disease.

Authors:  Mary K McCarthy; Bennett J J Davenport; Thomas E Morrison
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.737

Review 7.  Early Events in Chikungunya Virus Infection-From Virus Cell Binding to Membrane Fusion.

Authors:  Mareike K S van Duijl-Richter; Tabitha E Hoornweg; Izabela A Rodenhuis-Zybert; Jolanda M Smit
Journal:  Viruses       Date:  2015-07-07       Impact factor: 5.048

8.  First Chikungunya Outbreak in Suriname; Clinical and Epidemiological Features.

Authors:  Farah T van Genderen; Ingrid Krishnadath; Rachel Sno; Meritha G Grunberg; Wilco Zijlmans; Malti R Adhin
Journal:  PLoS Negl Trop Dis       Date:  2016-04-15

Review 9.  Interventions for treating patients with chikungunya virus infection-related rheumatic and musculoskeletal disorders: A systematic review.

Authors:  Arturo Martí-Carvajal; Pilar Ramon-Pardo; Emilie Javelle; Fabrice Simon; Sylvain Aldighieri; Hacsi Horvath; Julia Rodriguez-Abreu; Ludovic Reveiz
Journal:  PLoS One       Date:  2017-06-13       Impact factor: 3.240

10.  Health-related impact on quality of life and coping strategies for chikungunya: A qualitative study in Curaçao.

Authors:  Jelte Elsinga; Martin P Grobusch; Adriana Tami; Izzy Gerstenbluth; Ajay Bailey
Journal:  PLoS Negl Trop Dis       Date:  2017-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.